The intestinal microbiota and its role in human health and disease

Journal of Medical Investigation

Volumn 63, Issue 1-2, 2016, Pages 27-37

  Kataoka, Keiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bacteroides; Intestinal microbiota; Organic acid; Symbiotic relationship; Ulcerative colitis

Indexed keywords

BACTERIAL COLONIZATION; BACTERIUM CULTURE; BIFIDOBACTERIUM; DNA SEQUENCE; ENTEROCOCCUS; ESCHERICHIA COLI; FECES MICROFLORA; FERMENTED PRODUCT; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE ABSORPTION; INTESTINE FLORA; LACTOBACILLUS; LIFESTYLE; METABOLITE; MICROBIAL GROWTH; NONHUMAN; REVIEW; SYMBIOSIS; ULCERATIVE COLITIS; ADMINISTRATION AND DOSAGE; ANIMAL; COLITIS, ULCERATIVE; DIETARY FIBER; GENETICS; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; PHYSIOLOGY; RAT;

PREBIOTIC AGENT;

ANIMALS; COLITIS, ULCERATIVE; DIETARY FIBER; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; PREBIOTICS; RATS;

EID: 84962200721     PISSN: 13431420     EISSN: 13496867     Source Type: Journal    
DOI: 10.2152/jmi.63.27     Document Type: Review

References (77)

1. Smith K, McCoy KD, Macpherson AJ: Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin Immunol 19: 59-69, 2007
2. Rajilić-Stojanović M, de Vos WM: The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38: 996-1047, 2014
3. Mitsuoka T, Sega T, Yamamoto S: Improved methodology of qualitative and quantitative analysis of the intestinal flora of man and animals. Zentralbl Bakteriol Orig 195: 455-469, 1965
4. Momose Y, Maruyama A, Iwasaki T, Itoh K: 16S rRNA gene sequence-based analysis of clostridia related to conversion of germfree mice to the normal state. J Appl Microbiol 107: 2088-2097, 2009
5. Morita H, Kuwahara T, Ohshima K, Sasamoto H, Itoh K, Hattori M, Hayashi T, Takami H: An improved DNA isolation method for metagenomic analysis of the microbial flora of the human intestine. Microb Environ 22: 214-222, 2007
6. Zhu H, Qu F, Zhu LH: Isolation of genomic DNAs from plants, fungi and bacteria using benzyl chloride. Nucleic Acids Res 21: 5279-5280, 1993
7. Sakamoto M, Hayashi H, Benno Y: Terminal-restriction fragment length polymorphism analysis for human fecal microbiota and its application for analysis of complex bifidobacterial communities. Microbiol Immunol 47: 133-142, 2003
8. Jin JS, Touyama M, Hisada T, Benno Y: Effects of green tea consumption on human fecal microbiota with special reference to Bifidobacterium species. Microbiol Immunol 56: 729-739, 2012
9. Matsumoto M, Sakamoto M, Hayashi H, Benno Y: Novel phylogenetic assignment database for terminal-restriction fragment length polymorphism analysis of human colonic microbiota. J Microbiol Methods 61: 305-319, 2005
10. Nagashima K, Hisada T, Sato M, Mochizuki J: Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69: 1251-1262, 2003
11. Matsuki T, Watanabe K, Fujimoto J, Miyamoto Y, Takada T, Matsumoto K, Oyaizu H, Tanaka R: Development of 16S rRNAgene- targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68: 5445-5451, 2002
12. Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, Macfarlane S: Identification and quantification of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 53: 523-529, 2004
13. Rinttila T, Kassinen A, Malinen E, krogius L, Palva A: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97: 1166-1177, 2004
14. Song Y, Liu C, Finegold SM: Real-time PCR quantification of clostridia in feces of autistic children. Appl Environ Microbiol 70: 6459-6465, 2004
15. Layton A, McKay L, Williams D, Garrett V, Gentry R, Sayler G: Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water. Appl Environ Microbiol 72: 4214- 4224, 2006
16. Nemoto H, Ikata K, Arimochi H, Iwasaki T, Ohnishi Y, Kuwahara T, Kataoka K: Effects of fermented brown rice on the intestinal environments in healthy adult. J Med Invest 58: 235-245,2011
17. Nemoto H, Kataoka K, Ishikawa H, Ikata K, Arimochi H, Iwasaki T, Ohnishi Y, Kuwahara T, Yasutomo K: Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci 57: 2955-2964, 2012
18. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K: Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 75: 1961-1969, 2009
19. Hayashi H, Sakamoto M, Benno Y: Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46: 535-548, 2002
20. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J: Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65: 4799-4807, 1999
21. Yamada T: Metagenomics for human gut microbiome. J Intest Microbiol 29: 19-22, 2015
22. Takata T, Kado S, Nomoto K: Analysis of intestinal microflora by multicolor fluorescence in situ hybridization technology. J Intest Microbiol 29: 123-134, 2015
23. Swidsinski A, Loening-Baucke V, Herber A: Mucosal flora in Crohn’s Disease and ulcerative colitis- an overview. J Physiol Pharmacol 60 Suppl 6: 61-71, 2009
24. Johansson MEV, Gustafsson JK, Holmėn-Larsson J, Jabbar KS, Xia L, Xu H, Ghishan FK, Carvalho FA, Gewirtz AT, Sővall H, Hansson GC: Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut 63: 281-291, 2014
25. Sartor RB: Microbial influences in inflammatory bowel diseases. Gastroenterol 134: 577-594, 2008
26. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterol 136: 64-80, 2009
27. Deveraj S, Hemarajata P, Versalovic J: The human gut microbiome and body metabolism: Implications for obecity and diabetes. Clinical Chemistry 59: 617-628, 2013
28. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL: Nat Med 19: 576-585, 2013
29. Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, Patterson PH, Mazmanian SK: The microbiota modulates gut physiology and behavioral abnormalities associated with autism. Cell 155: 1451-1463, 2013
30. Kataoka K, Kibe R, Kuwahara T, Hagiwara M, Arimochi H, Iwasaki T, Benno Y, Ohnishi Y: Modifying effects of fermented brown rice on fecal microbiota in rats. Anaerobe 13: 220-227, 2007
31. Elson CO: Experimental models of intestinal inflammation. New insights into mechanisms of mucosal homeostasis. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, eds. Mucosal Immunology. Academic Press, 1999, pp.1007-1024
32. Kataoka K, Ogasa S, Kuwahara T, Bando Y, Hagiwara M, Arimochi H, Nakanishi S, Iwasaki T, Ohnishi Y: Inhibitory effects of fermented brown rice on induction of acute colitis by dextran sulfate sodium in rats. Dig Dis Sci 53: 1601-1608, 2008
33. Foligne B, Zoumpopoulou G, Dewulf J, Ben Younes A, Chareyre F, Sirard JC, Pot B, Grangette C: A key role of dendritic cells in probiotic functionality. PLoS One 2: e313, 2007
34. Round JL, O’Connell RM, Mazmanian SK: Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34: J220-J225, 2010
35. Geier MS, Butler RN, Howarth GS: Inflammatory bowel disease: Current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. International Journal of Food Microbiology 115: 1-11, 2007
36. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633, 2004
37. Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, Tandon RK: The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 7: 1202-1209, 2009
38. Ishikawa H, Matsumoto S, Ohashi Y, Imaoka A, Setoyama H, Umesaki Y, Tanaka R, Otani T: Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84: 128-133, 2011
39. Fujimori S, Gudis K, Mitsui K, Seo T, Yonezawa M, Tanaka S, Tatsuguchi A, Sakamoto C: A randomized controlled trial on the efficacy of symbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis. Nutrition 25: 520-525, 2009
40. Casellas F, Borruel N, Torrejon A, Varela E, Antolin M, Guarner F, Malagelada JR: Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated withlowered faecal calprotectin. Aliment Pharmacol Ther 25: 1061-1067, 2007
41. Kanauchi O, Mitsuyama K, Homma T, Takahama K, Fujiyama Y, Andoh A, Araki Y, Suga T, Hibi T, Naganuma M, Asakura H, Nakano H, Shimoyama T, Hida N, Haruma K, Koga H, Sata M, Tomiyasu N, Toyonaga A, Fukuda M, Kojima A, Bamba T: Treatment of ulcerative colitis patients by long-term administration of germinated barley stuff: multi-center open trial. Int J Mol Med 12: 701-704, 2003
42. Hanai H, Kanauchi O, Mitsuyama K, Andoh A, Takeuchi K, Takayuki I, Araki Y, Fujiyama Y, Toyonaga A, Sata M, Kojima A, Fukuda M, Bamba T: Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int J Mol Med 13: 643-647, 2004
43. Faghfoori Z, Navai L, Shakerhosseini R, Somi MH, Nikniaz Z, Norouzi MF: Effects of an oral supplementation of germinated barley foodstuff on serum tumour necrosis factor-alpha, interleukin-6 and-8 in patients with ulcerative colitis. Ann Clin Biochem 48: 233-237, 2011
44. Faghfoori Z, Shakerhosseini R, Navai L, Somi MH, Nikniaz Z, Abadi A: Effects of an oral supplementation of germinated barley foodstuff on serum CRP level and clinical signs in patients with ulcerative colitis. Health Promotion Perspectives 4: 116-121, 2014
45. Kanauchi O, Iwanaga T, Andoh A, Araki Y, Nakamura T, Mitsuyama K, Suzuki A, Hibi T, Bamba T: Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J Gastroenterol Hepatol 16: 160-168, 2001
46. Duncam SH, Louis P, Flint HJ: Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 70: 5810-5817, 2004
47. Duncan SH, Holtrop G, Lobley GE, Calder AG, Stewart CS, Flint HJ: Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 91: 915-923, 2004
48. Falony G, Vlachou A, Verbrugghe K, Vuyst LD: Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Environ Microbiol 72: 7835-7841, 2006
49. Andoh A, Sakata S, Koizumi Y, Mitsuyama K, Fujiyama Y, Benno Y: Terminal restriction fragment length polymorphism analysis of the diversity of fecal microbiota in patients with ulcerative colitis. Inflamm Bowel Dis 13: 955-962, 2007
50. Nishikawa J, Kudo T, Sakata S, Benno Y, Sugiyama T: Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis. Scand J Gastroenterol 44: 180-186, 2009
51. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J: Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55: 205-211, 2006
52. Martinez C, Antolin M, Santos J, Torrejon A, Casellas F, Borruel N, Guarner F, Malagelada JR: Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol 103: 643-648, 2008
53. Buffie CG, Pamer EG: Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews Immunology 13: 790-801, 2014
54. Cerf-Bensussan N, Gaboriau-Routhiau V: The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10: 735-744, 2010
55. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, Ohba Y, Taniguchi T, Takeda K, Hori S, Ivanov II, Umesaki Y, Itoh K, Honda K: Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331: 337-341, 2011
56. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H: Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446-450, 2013
57. Strober W, Watanabe T: NOD2, an intracellular innate immune sensor involved in host defense and Crohn’s disease. Mucosal Immunol 4: 484-495, 2011
58. Fritz T, Niederreiter L, Adolph T, Blumberg RS, Kaser A: Crohn’s disease: NOD2, autophagy and ER stress coverage. Gut 60: 1580-1588, 2011
59. Sheridan J, Mack DR, Amre DK, Israel DM, Cherkasov A, Li H, Grimard G, Steiner TS: A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn’s disease and influences responses to bacterial flagellin. PLoS One 8: e61326, 2013
60. Virgin HW, Levine B: Autophagy genes in immunity. Nat Immunol 10: 461-470, 2009
61. Borody TJ, Waren EF, Leis S, Surace R, Ashman O: Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 37: 42-47, 2003
62. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ: Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 44: 354-360, 2010
63. Collado MC, Cernada M, Bäuerl C, Vento M, Pérez-Martínez: Microbial ecology and host-microbiota interactions during early life stages. Gut Microbes 3: 352-365, 2012
64. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pederson BK, Al-soud WA, Sorensen SJ, Hansen LH, Jakobsen M: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085, 2010
65. Delzenne NM, Cani PD: Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 11: 154-159, 2011
66. Hildebrandt MA, Hoffman C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen Y-Y, Knight R, Ahima RS, Bushman F, Wu GD: High fat diet determines the composition of the murin gut microbiome independently of obesity. Gastroenterology 137: 1716-1724, 2009
67. Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR, Sikaroodi M, Gillevet PM: Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 60: 940-947, 2014
68. Schnabl B, Brenner DA: Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146: 1513-1524, 2014
69. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD: Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA 110: 9066-9071, 2013
70. Okubo H, Sakoda H, Kushiyama A, Fujishiro M, Nakatsu Y, Fukushima T, Matsunaga Y, Kamata H, Asahara T, Yoshida Y, Chonan O, Iwashita M, Nishimura F, Asano T: Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. Am J Physiol Gastrointest Liver Physiol 305: G911-G918, 2013
71. Albenberg LG, Wu GD: Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology 146: 1564-1572, 2014
72. Kibe R, Sakamoto M, Hayashi H, Yokota H, Benno Y: Maturation of the murine cecal microbiota as revealed by terminal restriction fragment length polymorphism and 16SrRNA gene clone libraries. FEMS Microbiol Lett 235: 139-146, 2004
73. Kelly D, King T, Aminov R: Importance of microbial colonization of the gut in early life to the development of immunity. Mutation Res 622: 58-69, 2007
74. Mulder IE, Schmidt B, Stokes CR, Lewis M, Bailey M, Aminov RI, Prosser JI, Gill BP, Pluske JR, Mayer CD, Musk CC, Kelly D: Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces. BMC Biology 7: 79, 2009
75. Hattori M, Taylor TD: The human intestinal microbiome: a new frontier of human biology. DNA Res 16: 1-12, 2009
76. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto J-M, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pederson O, Kristiansen K, Wang J: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490: 55-60, 2012
77. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clément K, Doré J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker J-D, Raes J, Hansen T, Meta HIT consortiam, Bork P, Wang J, Ehrlich SD, Pederson O: Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546, 2013